Annual CFI
-$61.00 K
+$679.00 K+91.76%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual cash flow from investing activities is -$61.00 thousand, with the most recent change of +$679.00 thousand (+91.76%) on March 31, 2024.
- During the last 3 years, VTGN annual CFI has risen by +$214.40 thousand (+77.85%).
Performance
VTGN Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
-$7.79 M
-$2.32 M-42.42%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly cash flow from investing activities is -$7.79 million, with the most recent change of -$2.32 million (-42.42%) on September 30, 2024.
- Over the past year, VTGN quarterly CFI has stayed the same.
- VTGN quarterly CFI is now -32407.05% below its all-time high of $24.10 thousand, reached on December 31, 2013.
Performance
VTGN Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$13.31 M
-$7.79 M-140.85%
September 30, 2024
Summary
- As of February 8, 2025, VTGN TTM cash flow from investing activities is -$13.31 million, with the most recent change of -$7.79 million (-140.85%) on September 30, 2024.
- Over the past year, VTGN TTM CFI has stayed the same.
- VTGN TTM CFI is now -55344.81% below its all-time high of $24.10 thousand, reached on September 30, 2014.
Performance
VTGN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VTGN Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +91.8% | 0.0% | 0.0% |
| 3 y3 years | +77.8% | 0.0% | 0.0% |
| 5 y5 years | +64.9% | 0.0% | 0.0% |
VTGN Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +91.8% | <-9999.0% | at low | <-9999.0% | at low |
| 5 y | 5-year | <-9999.0% | +91.8% | <-9999.0% | at low | <-9999.0% | at low |
| alltime | all time | <-9999.0% | +91.8% | <-9999.0% | at low | <-9999.0% | at low |
VistaGen Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.79 M(+42.4%) | -$13.31 M(+140.8%) |
| Jun 2024 | - | -$5.47 M(>+9900.0%) | -$5.53 M(+8962.3%) |
| Mar 2024 | -$61.00 K(-91.8%) | -$28.70 K(-11.1%) | -$61.00 K(-89.1%) |
| Dec 2023 | - | -$32.30 K(<-9900.0%) | -$560.30 K(+3.7%) |
| Sep 2023 | - | $0.00(0.0%) | -$540.50 K(-4.3%) |
| Jun 2023 | - | $0.00(-100.0%) | -$564.90 K(-23.7%) |
| Mar 2023 | -$740.00 K(+269.3%) | -$528.00 K(+4124.0%) | -$740.00 K(+248.9%) |
| Dec 2022 | - | -$12.50 K(-48.8%) | -$212.10 K(+6.3%) |
| Sep 2022 | - | -$24.40 K(-86.1%) | -$199.50 K(-11.6%) |
| Jun 2022 | - | -$175.10 K(>+9900.0%) | -$225.60 K(+12.6%) |
| Mar 2022 | -$200.40 K(-27.2%) | -$100.00(-200.0%) | -$200.40 K(-11.2%) |
| Dec 2021 | - | $100.00(-100.2%) | -$225.80 K(-40.1%) |
| Sep 2021 | - | -$50.50 K(-66.3%) | -$377.00 K(-11.4%) |
| Jun 2021 | - | -$149.90 K(+487.8%) | -$425.30 K(+54.4%) |
| Mar 2021 | -$275.40 K(<-9900.0%) | -$25.50 K(-83.1%) | -$275.40 K(+10.2%) |
| Dec 2020 | - | -$151.10 K(+52.9%) | -$249.90 K(+152.9%) |
| Sep 2020 | - | -$98.80 K(<-9900.0%) | -$98.80 K(<-9900.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2019 | - | $0.00(0.0%) | -$4200.00(0.0%) |
| Sep 2019 | - | $0.00(0.0%) | -$4200.00(-97.0%) |
| Jun 2019 | - | $0.00(-100.0%) | -$138.60 K(-20.3%) |
| Mar 2019 | -$174.00 K(>+9900.0%) | -$4200.00(<-9900.0%) | -$174.00 K(+2.5%) |
| Dec 2018 | - | $0.00(-100.0%) | -$169.80 K(0.0%) |
| Sep 2018 | - | -$134.40 K(+279.7%) | -$169.80 K(+358.9%) |
| Jun 2018 | - | -$35.40 K(<-9900.0%) | -$37.00 K(+2212.5%) |
| Mar 2018 | -$1600.00 | $0.00(0.0%) | -$1600.00(-99.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2017 | - | $0.00(-100.0%) | -$230.80 K(-0.9%) |
| Sep 2017 | - | -$1600.00(<-9900.0%) | -$233.00 K(-1.7%) |
| Jun 2017 | - | $0.00(-100.0%) | -$237.10 K(-0.8%) |
| Mar 2017 | -$239.10 K(+809.1%) | -$229.20 K(>+9900.0%) | -$239.10 K(+656.6%) |
| Dec 2016 | - | -$2200.00(-61.4%) | -$31.60 K(-7.1%) |
| Sep 2016 | - | -$5700.00(+185.0%) | -$34.00 K(+20.1%) |
| Jun 2016 | - | -$2000.00(-90.8%) | -$28.30 K(+7.6%) |
| Mar 2016 | -$26.30 K(<-9900.0%) | -$21.70 K(+371.7%) | -$26.30 K(+471.7%) |
| Dec 2015 | - | -$4600.00(<-9900.0%) | -$4600.00(<-9900.0%) |
| Sep 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2015 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2014 | - | $0.00(0.0%) | $24.10 K(>+9900.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2014 | -$9600.00(-92.9%) | $0.00(-100.0%) | -$9600.00(-30.9%) |
| Dec 2013 | - | $24.10 K(-200.0%) | -$13.90 K(-91.8%) |
| Sep 2013 | - | -$24.10 K(+151.0%) | -$169.10 K(+16.6%) |
| Jun 2013 | - | -$9600.00(+123.3%) | -$145.00 K(+7.1%) |
| Mar 2013 | -$135.40 K(+317.9%) | -$4300.00(-96.7%) | -$135.40 K(-9.8%) |
| Dec 2012 | - | -$131.10 K(<-9900.0%) | -$150.10 K(+510.2%) |
| Sep 2012 | - | $0.00(0.0%) | -$24.60 K(-24.1%) |
| Jun 2012 | - | $0.00(-100.0%) | -$32.40 K(0.0%) |
| Mar 2012 | -$32.40 K(+2392.3%) | -$19.00 K(+239.3%) | -$32.40 K(+141.8%) |
| Dec 2011 | - | -$5600.00(-28.2%) | -$13.40 K(+71.8%) |
| Sep 2011 | - | -$7800.00(<-9900.0%) | -$7800.00(<-9900.0%) |
| Jun 2011 | - | $0.00 | $0.00 |
| Dec 2008 | -$1300.00 | - | - |
FAQ
- What is VistaGen Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual CFI year-on-year change?
- What is VistaGen Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly CFI year-on-year change?
- What is VistaGen Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for VistaGen Therapeutics?
- What is VistaGen Therapeutics TTM CFI year-on-year change?
What is VistaGen Therapeutics annual cash flow from investing activities?
The current annual CFI of VTGN is -$61.00 K
What is the all time high annual CFI for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual cash flow from investing activities is $0.00
What is VistaGen Therapeutics annual CFI year-on-year change?
Over the past year, VTGN annual cash flow from investing activities has changed by +$679.00 K (+91.76%)
What is VistaGen Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of VTGN is -$7.79 M
What is the all time high quarterly CFI for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly cash flow from investing activities is $24.10 K
What is VistaGen Therapeutics quarterly CFI year-on-year change?
Over the past year, VTGN quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is VistaGen Therapeutics TTM cash flow from investing activities?
The current TTM CFI of VTGN is -$13.31 M
What is the all time high TTM CFI for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM cash flow from investing activities is $24.10 K
What is VistaGen Therapeutics TTM CFI year-on-year change?
Over the past year, VTGN TTM cash flow from investing activities has changed by $0.00 (0.00%)